Criée C P, Wilhelms E, Kneba M, Kreuzer H
Dtsch Med Wochenschr. 1984 Mar 30;109(13):499-500.
During treatment with the antiarrhythmic agent amiodarone pulmonary infiltrates may be observed occasionally. Such a side-effect was seen in a 67-year-old patient after several months of amiodarone therapy (200 mg/d during 5 days of the week). After withdrawal of the drug the infiltrates regressed over a period of two months. No other causes for the pulmonary opacities could be established. So far, 13 patients with pulmonary changes during amiodarone treatment have been reported in the literature.
在使用抗心律失常药物胺碘酮治疗期间，偶尔可观察到肺部浸润。一名67岁患者在接受胺碘酮治疗数月（每周5天，每天200毫克）后出现了这种副作用。停药后，浸润在两个月内消退。未发现肺部混浊的其他原因。迄今为止，文献中已报道了13例在胺碘酮治疗期间出现肺部改变的患者。
